PTGS1, PTGS2, ALOX5, ALOX12, ALOX15, and FLAP SNPs: Interaction with fatty acids in colon cancer and rectal cancer

Genes and Nutrition

Volumn 8, Issue 1, 2013, Pages 115-126

  Habermann, Nina ^a   Ulrich, Cornelia M ^a   Lundgreen, Abbie ^b   Makar, Karen W ^c   Poole, Elizabeth M ^d,e   Caan, Bette ^f   Kulmacz, Richard ^g   Whitton, John ^c   Galbraith, Rachel ^c   Potter, John D ^c   Slattery, Martha L ^b  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^c Fred Hutchinson Cancer Research Center   (United States)

^d BRIGHAM AND WOMEN S HOSPITAL   (United States)

^e HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^f KAISER PERMANENTE   (United States)

^g UNIVERSITY OF TEXAS   (United States)

Author keywords

Colon cancer; Fatty acid intake; Genetic variants; Rectal cancer

Indexed keywords

DOCOSAHEXAENOIC ACID; FATTY ACID; NONSTEROID ANTIINFLAMMATORY AGENT;

ADULT; AGED; ALOX12 GENE; ALOX15 GENE; ALOX5 GENE; ARTICLE; BODY MASS; CANCER RISK; CASE CONTROL STUDY; COLON CANCER; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG USE; FAT INTAKE; FEMALE; FLAP GENE; GENE; GENE INTERACTION; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; GENOTYPING TECHNIQUE; HETEROZYGOTE; HUMAN; INFLAMMATION RISK SCORE; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; PTGS1 GENE; PTGS2 GENE; RECTUM CANCER; SCORING SYSTEM; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING; VARIABLE NUMBER OF TANDEM REPEAT;

EID: 84872417020     PISSN: 15558932     EISSN: 18653499     Source Type: Journal    
DOI: 10.1007/s12263-012-0302-x     Document Type: Article

References (39)

1. Brenna JT, Salem N Jr, Sinclair AJ, Cunnane SC (2009) Alpha-linolenic acid supplementation and conversion to n-3 long-chain polyunsaturated fatty acids in humans. Prostaglandins Leukot Essent Fatty Acids 80(2-3):85-91. doi: 10.1016/j.plefa.2009.01.004
2. Busstra MC, Siezen CL, Grubben MJ, van Kranen HJ, Nagengast FM, van't Veer P (2003) Tissue levels of fish fatty acids and risk of colorectal adenomas: a case-control study (Netherlands). Cancer Causes Control 14(3):269-276
3. Calder PC (2008) The relationship between the fatty acid composition of immune cells and their function. Prostaglandins Leukot Essent Fatty Acids 79(3-5):101-108. doi: 10.1016/j.plefa.2008.09.016
4. Dommels YEM, Alink GM, van Bladeren PJ, van Ommen B (2002) Dietary n-6 and n-3 polyunsaturated fatty acids and colorectal carcinogenesis: results from cultured colon cells, animal models and human studies. Environ Toxicol Pharmacol 11(3-4):297-308
5. Geelen A, Schouten JM, Kamphuis C, Stam BE, Burema J, Renkema JM, Bakker EJ, van't Veer P, Kampman E (2007) Fish consumption, n-3 fatty acids, and colorectal cancer: a meta-analysis of prospective cohort studies. Am J Epidemiol 166(10):1116-1125. doi: 10.1093/aje/kwm197
6. Goodman JE, Bowman ED, Chanock SJ, Alberg AJ, Harris CC (2004) Arachidonate lipoxygenase (ALOX) and cyclooxygenase (COX) polymorphisms and colon cancer risk. Carcinogenesis 25(12):2467-2472. doi: 10.1093/carcin/bgh260
7. Hall MN, Chavarro JE, Lee IM, Willett WC, Ma J (2008) A 22-year prospective study of fish, n-3 fatty acid intake, and colorectal cancer risk in men. Cancer Epidemiol Biomarkers Prev 17(5):1136-1143. doi: 10.1158/1055-9965. EPI-07-2803
8. Hoshiko S, Radmark O, Samuelsson B (1990) Characterization of the human 5-lipoxygenase gene promoter. Proc Natl Acad Sci USA 87(23):9073-9077
9. In KH, Asano K, Beier D, Grobholz J, Finn PW, Silverman EK, Silverman ES, Collins T, Fischer AR, Keith TP, Serino K, Kim SW, De Sanctis GT, Yandava C, Pillari A, Rubin P, Kemp J, Israel E, Busse W, Ledford D, Murray JJ, Segal A, Tinkleman D, Drazen JM (1997) Naturally occurring mutations in the human 5-lipoxygenase gene promoter that modify transcription factor binding and reporter gene transcription. J Clin Investig 99(5):1130-1137
10. Janakiram NB, Mohammed A, Rao CV (2011) Role of lipoxins, resolvins, and other bioactive lipids in colon and pancreatic cancer. Cancer Metastasis Rev 30(3-4):507-523. doi: 10.1007/s10555-011-9311-2
11. Jump DB (2002) Dietary polyunsaturated fatty acids and regulation of gene transcription. Curr Opin Lipidol 13(2):155-164
12. Koh WP, Yuan JM, Van Den Berg D, Lee HP, Yu MC (2004) Interaction between cyclooxygenase-2 gene polymorphism and dietary n-6 polyunsaturated fatty acids on colon cancer risk: the Singapore Chinese health study. Br J Cancer 90:1760-1764
13. Larsson SC, Kumlin M, Ingelman-Sundberg M, Wolk A (2004) Dietary long-chain n-3 fatty acids for the prevention of cancer: a review of potential mechanisms. Am J Clin Nutr 79(6):935-945
14. Lee TH, Hoover RL, Williams JD, Sperling RI, Ravalese J III, Spur BW, Robinson DR, Corey EJ, Lewis RA, Austen KF (1985) Effect of dietary enrichment with eicosapentaenoic and docosahexaenoic acids on in vitro neutrophil and monocyte leukotriene generation and neutrophil function. N Engl J Med 312(19):1217-1224. doi: 10.1056/NEJM198505093121903
15. Lee CR, Bottone FG Jr, Krahn JM, Li L, Mohrenweiser HW, Cook ME, Petrovich RM, Bell DA, Eling TE, Zeldin DC (2007) Identification and functional characterization of polymorphisms in human cyclooxygenase-1 (PTGS1). Pharmacogenet Genomics 17(2):145-160. doi: 10.1097/01.fpc.0000236340.87540.e3
16. Norat T, Bingham S, Ferrari P, Slimani N, Jenab M, Mazuir M, Overvad K, Olsen A, Tjonneland A, Clavel F, Boutron-Ruault MC, Kesse E, Boeing H, Bergmann MM, Nieters A, Linseisen J, Trichopoulou A, Trichopoulos D, Tountas Y, Berrino F, Palli D, Panico S, Tumino R, Vineis P, Bueno-de-Mesquita HB, Peeters PH, Engeset D, Lund E, Skeie G, Ardanaz E, Gonzalez C, Navarro C, Quiros JR, Sanchez MJ, Berglund G, Mattisson I, Hallmans G, Palmqvist R, Day NE, Khaw KT, Key TJ, San Joaquin M, Hemon B, Saracci R, Kaaks R, Riboli E (2005) Meat, fish, and colorectal cancer risk: the European prospective investigation into cancer and nutrition. J Natl Cancer Inst 97(12):906-916. doi: 10.1093/jnci/dji164
17. Poole EM, Bigler J, Whitton J, Sibert JG, Potter JD, Ulrich CM (2006) Prostacyclin synthase and arachidonate 5-lipoxygenase polymorphisms and risk of colorectal polyps. Cancer Epidemiol Biomarkers Prev 15(3):502-508
18. Poole EM, Bigler J, Whitton J, Sibert JG, Kulmacz RJ, Potter JD, Ulrich CM (2007) Genetic variability in prostaglandin synthesis, fish intake and risk of colorectal polyps. Carcinogenesis 28(6):1259-1263. doi: 10.1093/carcin/bgm026
19. Pot GK, Geelen A, van Heijningen EM, Siezen CL, van Kranen HJ, Kampman E (2008) Opposing associations of serum n-3 and n-6 polyunsaturated fatty acids with colorectal adenoma risk: an endoscopy-based case-control study. Int J Cancer 123(8):1974-1977. doi: 10.1002/ijc.23729
20. Reddy BS, Maeura Y (1984) Tumor promotion by dietary fat in azoxymethane-induced colon carcinogenesis in female F344 rats: influence of amount and source of dietary fat. J Natl Cancer Inst 72(3):745-750
21. Sayers I, Barton S, Rorke S, Sawyer J, Peng Q, Beghe B, Ye S, Keith T, Clough JB, Holloway JW, Sampson AP, Holgate ST (2003) Promoter polymorphism in the 5-lipoxygenase (ALOX5) and 5-lipoxygenase-activating protein (ALOX5AP) genes and asthma susceptibility in a Caucasian population. Clin Exp Allergy 33(8):1103-1110
22. Serhan CN (2005) Novel eicosanoid and docosanoid mediators: resolvins, docosatrienes, and neuroprotectins. Curr Opin Clin Nutr Metab Care 8(2):115-121
23. Serhan CN, Yacoubian S, Yang R (2008) Anti-inflammatory and proresolving lipid mediators. Annu Rev Pathol 3:279-312. doi: 10.1146/annurev.pathmechdis.3. 121806.151409
24. Shapiro AC, Wu D, Meydani SN (1993) Eicosanoids derived from arachidonic and eicosapentaenoic acids inhibit T cell proliferative response. Prostaglandins 45(3):229-240
25. Siezen CL, van Leeuwen AI, Kram NR, Luken ME, van Kranen HJ, Kampman E (2005) Colorectal adenoma risk is modified by the interplay between polymorphisms in arachidonic acid pathway genes and fish consumption. Carcinogenesis 26(2):449-457. doi: 10.1093/carcin/bgh336
26. Siezen CL, Bueno-de-Mesquita HB, Peeters PH, Kram NR, van Doeselaar M, van Kranen HJ (2006a) Polymorphisms in the genes involved in the arachidonic acid-pathway, fish consumption and the risk of colorectal cancer. Int J Cancer 119(2):297-303. doi: 10.1002/ijc.21858
27. Siezen CL, Tijhuis MJ, Kram NR, van Soest EM, de Jong DJ, Fodde R, van Kranen HJ, Kampman E (2006b) Protective effect of nonsteroidal anti-inflammatory drugs on colorectal adenomas is modified by a polymorphism in peroxisome proliferator-activated receptor delta. Pharmacogenet Genomics 16(1):43-50
28. Slattery ML, Caan BJ, Duncan D, Berry TD, Coates A, Kerber R (1994a) A computerized diet history questionnaire for epidemiologic studies. J Am Diet Assoc 94(7):761-766
29. Slattery ML, Dyer A, Jacobs DR Jr, Hilner JE, Caan BJ, Bild DE, Liu K, McDonald A, Van Horn L, Hardin M (1994b) A comparison of two methods to ascertain dietary intake: the CARDIA Study. J Clin Epidemiol 47(7):701-711
30. Slattery ML, Edwards SL, Ma KN, Friedman GD, Potter JD (1997a) Physical activity and colon cancer: a public health perspective. Ann Epidemiol 7(2):137-145
31. Slattery ML, Potter J, Caan B, Edwards S, Coates A, Ma KN, Berry TD (1997b) Energy balance and colon cancer-beyond physical activity. Cancer Res 57(1):75-80
32. Slattery ML, Potter JD, Duncan DM, Berry TD (1997c) Dietary fats and colon cancer: assessment of risk associated with specific fatty acids. Int J Cancer 73(5):670-677
33. Slattery ML, Benson J, Ma KN, Schaffer D, Potter JD (2001) Trans-fatty acids and colon cancer. Nutr Cancer 39(2):170-175
34. Tan XL, Nieters A, Hoffmeister M, Beckmann L, Brenner H, Chang-Claude J (2007) Genetic polymorphisms in TP53, nonsteroidal anti-inflammatory drugs and the risk of colorectal cancer: evidence for gene-environment interaction? Pharmacogenet Genomics 17(8):639-645. doi: 10.1097/FPC.0b013e3280d5121c
35. Ulrich CM, Whitton J, Yu JH, Sibert J, Sparks R, Potter JD, Bigler J (2005) PTGS2 (COX-2) -765 G > C promoter variant reduces risk of colorectal adenoma among nonusers of nonsteroidal anti-inflammatory drugs. Cancer Epidemiol Biomarkers Prev 14(3):616-619
36. Ulrich CM, Bigler J, Potter JD (2006) Non-steroidal anti-inflammatory drugs for cancer prevention: promise, perils and pharmacogenetics. Nat Rev Cancer 6(2):130-140. doi: 10.1038/nrc1801
37. Wang YC, Kuo WH, Chen CY, Lin HY, Wu HT, Liu BH, Chen CH, Mersmann HJ, Chang KJ, Ding ST (2010) Docosahexaenoic acid regulates serum amyloid A protein to promote lipolysis through down regulation of perilipin. J Nutr Biochem 21(4):317-324. doi: 10.1016/j.jnutbio.2009.01.004
38. WCRF, AICR (2007) Food, nutrition, physical activity, and the prevention of cancer: a global perpective. AICR, Washington, DC
39. Woutersen RA, Appel MJ, van Garderen-Hoetmer A, Wijnands MV (1999) Dietary fat and carcinogenesis. Mutat Res 443(1-2):111-127